Furthermore, Wnt-induced signaling protein 1 (WISP1) plays a vital role in the maintenance of TAMs and glioma stem cells, suggesting that targeting Wnt/β-catenin-WISP1 signaling may improve survival and treatment outcomes in GBM patients (89). This evidence concerns the gene CCN4 and central nervous system cancer.